DK1249450T3 - Benzimidazolderivater som human chymase-inhibitorer - Google Patents

Benzimidazolderivater som human chymase-inhibitorer

Info

Publication number
DK1249450T3
DK1249450T3 DK01901397T DK01901397T DK1249450T3 DK 1249450 T3 DK1249450 T3 DK 1249450T3 DK 01901397 T DK01901397 T DK 01901397T DK 01901397 T DK01901397 T DK 01901397T DK 1249450 T3 DK1249450 T3 DK 1249450T3
Authority
DK
Denmark
Prior art keywords
halo
optionally substituted
oxo
trihalomethyl
alk
Prior art date
Application number
DK01901397T
Other languages
Danish (da)
English (en)
Inventor
Naoki Tsuchiya
Yoshiyuki Matsumoto
Hiroshi Saitou
Tsuyoshi Mizuno
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Application granted granted Critical
Publication of DK1249450T3 publication Critical patent/DK1249450T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK01901397T 2000-01-17 2001-01-17 Benzimidazolderivater som human chymase-inhibitorer DK1249450T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000007533 2000-01-17
JP2000392303 2000-12-25
PCT/JP2001/000271 WO2001053291A1 (fr) 2000-01-17 2001-01-17 Derives benzimidazoles

Publications (1)

Publication Number Publication Date
DK1249450T3 true DK1249450T3 (da) 2008-02-11

Family

ID=26583615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01901397T DK1249450T3 (da) 2000-01-17 2001-01-17 Benzimidazolderivater som human chymase-inhibitorer

Country Status (19)

Country Link
EP (1) EP1249450B1 (xx)
JP (1) JP4059671B2 (xx)
KR (2) KR100763779B1 (xx)
CN (2) CN100415723C (xx)
AT (1) ATE375156T1 (xx)
AU (2) AU777813B2 (xx)
CA (1) CA2396908A1 (xx)
CZ (1) CZ301504B6 (xx)
DE (1) DE60130865T2 (xx)
DK (1) DK1249450T3 (xx)
ES (1) ES2295128T3 (xx)
HK (1) HK1050009A1 (xx)
IL (1) IL150565A0 (xx)
NO (1) NO324049B1 (xx)
NZ (1) NZ520028A (xx)
PT (1) PT1249450E (xx)
RU (1) RU2263674C2 (xx)
SI (1) SI1249450T1 (xx)
WO (1) WO2001053291A1 (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522150A (en) 2001-02-22 2006-03-31 Teijin Ltd Benzo[b]thiophene derivatives and processes for preparing the same
EP1298130B1 (en) 2001-05-07 2008-08-13 Teijin Pharma Limited 3-hydroxymethylbenzo b thiophene derivatives and process for their preparation
NZ528291A (en) * 2001-08-24 2007-03-30 Teijin Ltd Drugs containing chymase inhibitor and ace inhibitor as the active ingredients
CL2004001034A1 (es) * 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
WO2005018672A1 (ja) * 2003-08-22 2005-03-03 Teijin Pharma Limited キマーゼ阻害剤を有効成分として含有する薬剤
EP1826207A4 (en) * 2004-11-12 2009-05-20 Teijin Pharma Ltd ACID SALT OF A BENZIMIDAZOLE DERIVATIVE AND CRYSTAL THEREOF
CN101291656B (zh) 2005-08-18 2012-11-07 帝人制药株式会社 具有准确的用量分割功能的制剂
EP1915988A4 (en) 2005-08-18 2012-07-25 Teijin Pharma Ltd COMPRESSOR COMPRISING MULTIPLE SEGMENTS CONTAINING MEDICAMENTS
TW200734321A (en) 2005-10-27 2007-09-16 Teijin Pharma Ltd Benzo [b] thiophen derivatives and a process for producing benzo [b] thiophen derivatives
TW200734320A (en) 2005-10-27 2007-09-16 Teijin Pharma Ltd 3-Hydroxymethylbenzo [b] thiophen derivatives and a process for producing 3-hydroxymethylbenzo [b] thiophen derivatives
PE20070698A1 (es) 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
UA95788C2 (xx) * 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Конденсовані похідні піролу$кондесированные производные пиррола
CA2687821C (en) 2007-05-22 2015-04-14 Boehringer Ingelheim International Gmbh Benzimidazolone chymase inhibitors
CA2686651C (en) * 2007-05-25 2015-11-24 Abbott Gmbh & Co. Kg Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
TW200916098A (en) * 2007-06-14 2009-04-16 Teijin Pharma Ltd Agent for lowering uric acid level
WO2009133964A1 (ja) * 2008-04-28 2009-11-05 国立大学法人九州大学 酸化ストレス抑制剤
CA2736522C (en) 2008-09-09 2016-09-13 Boehringer Ingelheim International Gmbh Aza-benzimidazolone chymase inhibitors
WO2010036613A1 (en) 2008-09-26 2010-04-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CA2741125A1 (en) 2008-10-22 2010-04-29 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2010051176A1 (en) 2008-10-29 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CN102271509A (zh) 2008-10-31 2011-12-07 默沙东公司 用于抗糖尿病药的新型环苯并咪唑衍生物
MX2012005329A (es) * 2009-11-18 2012-05-29 Astrazeneca Ab Compuestos benzoimidazolicos y sus usos.
US8895596B2 (en) 2010-02-25 2014-11-25 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
EP2677869B1 (en) 2011-02-25 2017-11-08 Merck Sharp & Dohme Corp. Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
CA2872000A1 (en) * 2012-05-04 2013-11-07 Novartis Ag Complement pathway modulators and uses thereof
CA2880901A1 (en) 2012-08-02 2014-02-06 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
EP2906040B1 (en) 2012-08-22 2021-02-17 Merck Sharp & Dohme Corp. Novel benzimidazole tetrahydropyran derivatives
US9382243B2 (en) 2012-08-22 2016-07-05 Merck Sharp & Dohme Corp. Azabenzimidazole tetrahydropyran derivatives
EP2887807B1 (en) 2012-08-22 2019-09-18 Merck Sharp & Dohme Corp. Benzimidazole hexahydrofuro[3,2-b]furan derivatives useful as amp-activated protein kinase activators
EP2888008B1 (en) 2012-08-22 2018-12-26 Merck Sharp & Dohme Corp. Novel azabenzimidazole tetrahydrofuran derivatives
WO2014031441A1 (en) 2012-08-22 2014-02-27 Merck Sharp & Dohme Corp. Novel benzimidazole tetrahydrofuran derivatives
BR112015003109A2 (pt) 2012-08-22 2017-08-15 Merck Sharp & Dohme Composto, composição, uso de um composto, e, métodos para tratar ou prevenir um distúrbio, condição ou doença e para tratar diabetes mellitus tipo 2.
EP2970119B1 (en) 2013-03-14 2021-11-03 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US10519115B2 (en) 2013-11-15 2019-12-31 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2015089809A1 (en) 2013-12-19 2015-06-25 Merck Sharp & Dohme Corp. Antidiabetic substituted heteroaryl compounds
CN111004125B (zh) * 2019-12-24 2022-11-22 东华理工大学 一种缩醛或缩酮化合物的制备方法
CN116903541B (zh) * 2023-08-14 2023-12-08 中国环境科学研究院 用于酚类污染物检测的酰基咪唑类化合物、制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430950A1 (fr) * 1978-07-10 1980-02-08 Delalande Sa Nouveaux derives heterocycliques de la benzimidazole, leur procede de preparation et leur application en therapeutique
DE2928055A1 (de) * 1978-07-12 1980-01-31 Eastman Kodak Co Verfahren zur verbesserung der widerstandsfaehigkeit von polyesterformkoerpern gegenueber einem abbau durch u.v.- licht
JPS62212386A (ja) * 1986-03-14 1987-09-18 Suntory Ltd ２−ピリジルメチルベンズイミダゾ−ル誘導体
JPH01265089A (ja) * 1988-04-15 1989-10-23 Zeria Pharmaceut Co Ltd 新規１−（イミダゾール−４−イル）メチルベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
GB9225141D0 (en) * 1992-12-01 1993-01-20 Smithkline Beecham Corp Chemical compounds
US5527597A (en) * 1995-03-01 1996-06-18 Southern Mills, Inc. Stretchable flame resistant fabric
WO1999026932A1 (en) * 1997-11-26 1999-06-03 Axys Pharmaceuticals, Inc. By amidino group substituted heterocyclic derivatives and their use as anticoagulants
JP3923255B2 (ja) * 1998-07-15 2007-05-30 帝人株式会社 チオベンズイミダゾール誘導体
EA004746B1 (ru) * 1999-06-28 2004-08-26 Янссен Фармацевтика Н.В. Производные бензимидазола и имидазопиридина в качестве ингибиторов репликации респираторно-синцитиального вируса
CZ2001153A3 (cs) * 1999-07-14 2001-06-13 Teijin Ltd Thiobenzimidazolové deriváty

Also Published As

Publication number Publication date
AU2005200172A1 (en) 2005-02-10
NO20023415D0 (no) 2002-07-16
AU777813B2 (en) 2004-11-04
HK1050009A1 (en) 2003-06-06
IL150565A0 (en) 2003-02-12
KR100763779B1 (ko) 2007-10-05
CN1680339A (zh) 2005-10-12
PT1249450E (pt) 2008-01-02
NZ520028A (en) 2004-07-30
NO20023415L (no) 2002-07-16
SI1249450T1 (sl) 2008-04-30
DE60130865D1 (de) 2007-11-22
CZ301504B6 (cs) 2010-03-24
CN100415723C (zh) 2008-09-03
ATE375156T1 (de) 2007-10-15
NO324049B1 (no) 2007-08-06
CN1418211A (zh) 2003-05-14
KR20020065929A (ko) 2002-08-14
CN1198819C (zh) 2005-04-27
ES2295128T3 (es) 2008-04-16
RU2263674C2 (ru) 2005-11-10
EP1249450B1 (en) 2007-10-10
EP1249450A1 (en) 2002-10-16
EP1249450A4 (en) 2003-04-09
JP4059671B2 (ja) 2008-03-12
CA2396908A1 (en) 2001-07-26
DE60130865T2 (de) 2008-07-17
KR20070057276A (ko) 2007-06-04
AU2704901A (en) 2001-07-31
RU2002122105A (ru) 2004-01-10
WO2001053291A1 (fr) 2001-07-26
AU2005200172B2 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
DK1249450T3 (da) Benzimidazolderivater som human chymase-inhibitorer
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
DE502004005959D1 (de) Pyrimidin-2-on-verbindungen und ihre verwendung als dopamin-d3-rezeptorliganden
HU0900587D0 (en) Stable salts of 3,3-diphenylpropylamines and preparation thereof
ATE540938T1 (de) Neue benzoxazinonderivate als langwirksame betamimetika zur behandlung von atemwegserkrankungen
RU2003136097A (ru) Производные фенилпиридинкарбонилпиперазина
ECSP055644A (es) Derivados de la quinolil-propil-piperidina y su utilización
DE69132713D1 (de) Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren
NO20044041L (no) Okso-azabisykliske forbindelser
TW200504085A (en) Derivatives of [2-(8,9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof
ATE502936T1 (de) 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
JP2011510072A5 (xx)
CY1110465T1 (el) Υποκατεστημενα παραγωγα ιμιδαζολινης
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
ES2172436A1 (es) Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
KR950032194A (ko) 신규푸린유도체 및 그 약학적으로 허용되는 염
DE69414396D1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
JPH083044A (ja) 骨粗鬆症の予防または治療剤
AR035219A1 (es) Compuesto de 1, 2, 3, 4, 4a, 5, 6, 7, 8, 8 a-decahidroisoquinolina, su uso para preparar una composicion farmaceutica, dicha composicion farmaceutica y procedimiento para preparar dicho compuesto
DE69904427D1 (de) Benzothiophenderivate als antithrombotische Mitteln und Zwischenprodukte
HUP0204131A2 (hu) Szacharinszármazékok, mint orálisan aktív elasztáz inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
JP2002201130A (ja) 炎症性サイトカインおよびプロスタノイド産生抑制剤